title: Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes.
abstract: The continuous advance in the search for the cause and pathogenesis of the autoinflammatory syndromes, as well as reports of the efficacy of specific inflammation-mediator suppressors, has changed the way these syndromes are approached and treated; both the acute and long-term treatment of these diseases has improved significantly. Etiologic and pathophysiologic manipulation is and will be the future for controlling, even curing, this new and rare set of diseases.
authors.affiliation: Miami Medical Consult, 4950 South Le Jeune Road, Suite H, Coral Gables, FL 33146, USA. gsterba@miamimedconsult.com
authors.forename: Gary
authors.initials: G
authors.lastname: Sterba
authors.forename: Yonit
authors.initials: Y
authors.lastname: Sterba
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D056660:Hereditary Autoinflammatory Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000276:immunology / Q000627:therapeutic use; D013577:Syndrome
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D053590:Interleukin 1 Receptor Antagonist Protein
keywords: Anakinra; Autoinflammation; Treatment